Labetalol Hcl Injection
Product Images NDC 51662-1602

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Labetalol Hcl (NDC 51662-1602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Labeling (51662 1602 1 Serialized Box Labeling)

This is a label for a multi-dose vial of Labetalol injection, which is a medication used for intravenous injection to treat high blood pressure. The vial contains 100 mg of the medication in 20 mL of solution, at a concentration of 5 mg/mL. The label indicates that it is only for intravenous injection and is sterile. Manufacturer is Westward.*

FDA Label Image

Adverse (Adverse)

This appears to be a chart or table showing the frequency of certain symptoms experienced by individuals taking a medication called ETEE at a 200mg dose. The symptoms listed include nausea, vomiting, fatigue, dyspepsia, paresthesia, and edema, among others. The chart also lists the number of individuals reporting each symptom in 9 different categories, labeled DDZ, Heimd, and numbers 52, 181, 606, 608, 503, 117, 242, and 175.*

FDA Label Image

Box Labeling (Box Labeling)

This is a label of a medication called Labetalol HCI Injection. It is a sterile solution for intravenous injection only, and should not be frozen. It comes in a 20 mL multiple dose vial, and the usual dosage should be determined by a physician. The solution contains labetalol hydrochloride, methylparaben, and propylparaben as preservatives. The medication is distributed by HIKMA PHARMACEUTICALS and is Rxonly. The label includes the NDC numbers and storage instructions.*

FDA Label Image

Dosage (Dosage)

This text provides instructions for inpatient titration with four different regimens ranging from 200 mg b.i.d. to 1,200 mq b.i.d., with corresponding daily doses ranging from 400 mg to 2,400 mg. It also notes that if necessary, the total daily dose can be divided into three separate doses.*

FDA Label Image

Structure (Structure)

FDA Label Image

Vial Label (Vial Label)

This is the product information for the drug "Labetalol Injection, USP". It is a clear, colorless solution for intravenous administration, with a concentration of 5 mg/mL. It is intended for intravenous use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.